NCT05784467View on ClinicalTrials.gov

Methamphetamine, PrEP, and Intersectional Stigma Study

NANot yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

May 1, 2026

Study Completion Date

August 31, 2027

Conditions
Methamphetamine AbuseHivSocial Stigma
Interventions
BEHAVIORAL

Methamphetamine, PrEP, and Intersectional Stigma (eMPrISe) study

Group behavioral intervention with 12 weekly sessions lasting 2 hours focusing on coping, resistance, and resilience.

All Listed Sponsors
lead

Arizona State University

OTHER

NCT05784467 - Methamphetamine, PrEP, and Intersectional Stigma Study | Biotech Hunter | Biotech Hunter